Deals

MicuRx Pharmaceuticals Licenses MRX‑23 ADC and STOPIN Platform to ClearideBio in Multi‑Asset Global Deal Worth Up to USD 973 Million
ADC / XDCClearideBio Therapeutics

MicuRx Pharmaceuticals Licenses MRX‑23 ADC and STOPIN Platform to ClearideBio in Multi‑Asset Global Deal Worth Up to USD 973 Million

Shanghai MicuRx Pharmaceuticals, Inc. (SHA: 688373) announced that it intends to enter into an MRX‑23 License Agreement and a Platform Technology Cooperation Agreement with ClearideBio Therapeutics AG, a Switzerland‑based biopharmaceutical…

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Simcere Pharma to Spin Off Zaiming Unit for Hong Kong IPO
ADC / XDCCancer

Simcere Pharma to Spin Off Zaiming Unit for Hong Kong IPO

Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform
CAR-THBM Holdings

Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform

AICancer

Pierre Fabre Partners with Iktos on AI-Driven Oncology Drug Discovery

Haisco Licenses COPD Drug HSK39004 to AirNexis for $1.06 Billion
AirNexis TherapeuticsHaisco Pharmaceutical

Haisco Licenses COPD Drug HSK39004 to AirNexis for $1.06 Billion

Show More